{
  "ticker": "LLY",
  "target_date": "2025-07-29",
  "actual_date": "2025-07-29",
  "collected_at": "2025-12-08T12:04:29.899270",
  "price": {
    "open": 771.67,
    "high": 776.64,
    "low": 752.42,
    "close": 760.1615600585938,
    "volume": 7100700,
    "change_1d_pct": -5.59,
    "change_7d_pct": -1.14,
    "change_30d_pct": -6.88
  },
  "technicals": {
    "rsi_14": 44.19,
    "sma_20": 781.02,
    "sma_50": 770.25,
    "macd": 2.461,
    "macd_signal": 1.799,
    "macd_histogram": 0.661,
    "bb_upper": 811.81,
    "bb_lower": 750.24,
    "price_vs_sma20_pct": -2.67,
    "price_vs_sma50_pct": -1.31,
    "volume_ratio": 2.3
  },
  "fundamentals": {
    "market_cap": 892077539328,
    "pe_ratio": 48.75625,
    "forward_pe": 43.915047,
    "price_to_book": 37.46668,
    "price_to_sales": 15.013136,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.51,
    "pct_from_52w_low": 59.53
  },
  "macro": {
    "spy": {
      "price": 633.5,
      "change_1d_pct": -0.26,
      "change_7d_pct": 1.03
    },
    "vix": {
      "level": 15.98,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.33
    },
    "dollar_index": {
      "level": 98.91
    },
    "gold": {
      "price": 3323.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Novo Nordisk shares plunge after profit warning over US weight-loss copycats",
      "source": "Yahoo",
      "datetime": 1753830788,
      "summary": "Novo Nordisk\u2019s shares plunged more than a fifth on Tuesday, wiping more than \u20ac60bn from its value, after it slashed sales and profit forecasts...",
      "url": "https://finnhub.io/api/news?id=478d7cc16776c84fa83037b9704920dded7778828bd825d3407a33dc447ef64e"
    },
    {
      "headline": "Why Eli Lilly Stock Was Looking Sickly Today",
      "source": "Yahoo",
      "datetime": 1753826815,
      "summary": "It seemed the market overreacted to discouraging news from one of the company's rivals.",
      "url": "https://finnhub.io/api/news?id=d98a2894aabb8c95f7a4ee3bba5b58419d7257921a596de479f47fb6b422d1ef"
    },
    {
      "headline": "LipoVive Releases Ingredient Report Comparing Natural GLP-1 Support to Synthetic Drugs Like Mounjaro",
      "source": "Yahoo",
      "datetime": 1753825920,
      "summary": "A Plant-Based Formula With Science-Referenced Compounds Designed to Support Hormonal Weight Balance Without Prescription MedicationsNew York, July 29, 2025 (GLOBE NEWSWIRE) -- Disclaimer: The information provided in this article is for educational and informational purposes only. It does not constit",
      "url": "https://finnhub.io/api/news?id=4677d199a5aaa94860391383a9d95e8f4f740dbdd11f31ac6049822b2bd1c4ce"
    },
    {
      "headline": "Eli Lilly (LLY) Declines More Than Market: Some Information for Investors",
      "source": "Yahoo",
      "datetime": 1753825502,
      "summary": "Eli Lilly (LLY) reached $762.95 at the closing of the latest trading day, reflecting a -5.59% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=41cf4a8e76de290acba48c859d9a6b8a2c46c1185246bd2b48aa0c46bfb5dba7"
    },
    {
      "headline": "Lilly set for strong quarter after Novo profit warning",
      "source": "Yahoo",
      "datetime": 1753818579,
      "summary": "(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term heal",
      "url": "https://finnhub.io/api/news?id=fd7a009ce6a5b955c106560127251aad0133406c6d7144ee292b9fcfa84b2e10"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-07-25",
      "description": "xslF345X05/form4-07252025_040701.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925020284/xslF345X05/form4-07252025_040701.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753219662.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/xslF345X05/wk-form4_1753219662.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753217727.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000194/xslF345X05/wk-form4_1753217727.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753216439.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/xslF345X05/wk-form4_1753216439.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753215735.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000184/xslF345X05/wk-form4_1753215735.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}